BlackRock
CHTP

BlackRock’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

BlackRock’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,897
Closed -$10K – 3306
2014
Q1 		$10K Hold
1,897
– – ﹤0.01% 2756
2013
Q4 		$8K Hold
1,897
– – ﹤0.01% 2896
2013
Q3 		$6K Buy
+1,897
New +$5.45K ﹤0.01% 2972

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BlackRock's CHTP Position: Q2 2014 in Review

BlackRock sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 1,897 shares — an estimated $10K sold.

BlackRock first reported a position in CHTP in Q3 2013 and held it in 3 quarters. The position peaked at $10K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • BlackRock reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • BlackRock sold 1,897 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $10K.
  • BlackRock first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 3 quarters.
  • BlackRock's CHELSEA THERAPEUTICS INT'L LTD position peaked at $10K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on BlackRock's 13F filing for Q2 2014, filed 6 Aug 2014.